Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective
According to the results of FLOT4 trial, perioperative FLOT chemotherapy improved overall survival (OS) in locally advanced, resectable esophagogastric adenocarcinoma (EGA) compared to perioperative ECF/ECX. We report real-life data 10 years after introduction of perioperative FLOT at our institutio...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
10 February 2023
|
| In: |
Langenbeck's archives of surgery
Year: 2023, Volume: 408, Pages: 1-15 |
| ISSN: | 1435-2451 |
| DOI: | 10.1007/s00423-023-02822-7 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00423-023-02822-7 |
| Author Notes: | Leila Sisic, Nerma Crnovrsanin, Henrik Nienhueser, Jin-On Jung, Sabine Schiefer, Georg Martin Haag, Thomas Bruckner, Martin Schneider, Beat P. Müller-Stich, Markus W. Büchler, Thomas Schmidt |
| Summary: | According to the results of FLOT4 trial, perioperative FLOT chemotherapy improved overall survival (OS) in locally advanced, resectable esophagogastric adenocarcinoma (EGA) compared to perioperative ECF/ECX. We report real-life data 10 years after introduction of perioperative FLOT at our institution. |
|---|---|
| Item Description: | Gesehen am 17.03.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1435-2451 |
| DOI: | 10.1007/s00423-023-02822-7 |